Fox Christine Ann 4
4 · Mereo BioPharma Group plc · Filed Jun 25, 2024
Insider Transaction Report
Form 4
Fox Christine Ann
Chief Financial Officer
Transactions
- Exercise/Conversion
American Depositary Shares representing Ordinary Shares
2024-06-21+90,000→ 100,000 total - Exercise/Conversion
Performance Based Restricted Stock Unit
2024-06-21+90,000→ 60,000 totalExercise: $0.00From: 2024-06-21Exp: 2025-01-25→ American Depository Shares (90,000 underlying)
Footnotes (2)
- [F1]Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.
- [F2]Represents performance-based restricted stock unit ("PSU") earned under the issuer's 2019 Employee Incentive Plan (the "Plan") that vested on June 21, 2024 based on satisfaction of ADS price threshold values over a two year performance period (expiring on January 1, 2025).